Arkolith/Insider Trading/GRTX/Form 4

Beardsley Robert A

Chief Operating OfficerGalera Therapeutics, Inc. (GRTX) · full profile →Form 4 · filed Dec 20, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2021Option exercise(M)20K$1.07$21K88K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2021Option exercise(M)20K—$096K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-049011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML